STOCK MARKET Natco Pharma shares surge over 3% after board approves demerger of agrochemicals business Mar 25, 2026
NATCO Pharma gets CDSCO approval for Generic Semaglutide Injection, launch set for March 2026 Feb 14, 2026
NATCO Pharma concludes US FDA inspection at Chennai API unit, receives seven form 483 observations Nov 21, 2025
NATCO Pharma Q2 Results: Net profit drops 23% YoY to Rs 518 crore, revenue flat at Rs 1,363 crore Nov 14, 2025